Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00044863
Status:
COMPLETED
Last Update Posted:
2011-02-23
First Post:
2002-09-05
Brief Title:
Study of Erbitux Cetuximab in Patients With Metastatic Colorectal Carcinoma
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-08
Start Date Type:
None
Primary Completion Date:
2005-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-12
Completion Date Type:
ACTUAL
First Submit Date:
2002-09-05
First Submit QC Date:
September 6 2002
Study First Post Date:
2002-09-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-02-21
Last Update Post Date:
2011-02-23
Last Update Post Date Type:
ESTIMATED